Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuclear scintigraphy evaluation of teriparatide anabolic effects in postmenopausal osteoporosis
2005-002174-30Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of teriparatide in osteoporosis, sponsored by Eli Lilly and Company. Primary endpoint: Change in whole body skeletal plasma clearance of 99mTc-MDP. Started Aug 2005; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2005-002174-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002174-30.